Cargando…

Public perceptions of naloxone use in the outpatient setting

INTRODUCTION: Naloxone has become an important component of preventing deaths from opioid overdose. Although studies have confirmed its cost-effectiveness, naloxone is rarely prescribed proactively in case of accidental overdose. The perception still exists that a reversal agent may enable patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jordan O., Malinowski, Scott S., Ballou, Jordan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607948/
https://www.ncbi.nlm.nih.gov/pubmed/31293847
http://dx.doi.org/10.9740/mhc.2019.07.275
_version_ 1783432175116353536
author Smith, Jordan O.
Malinowski, Scott S.
Ballou, Jordan M.
author_facet Smith, Jordan O.
Malinowski, Scott S.
Ballou, Jordan M.
author_sort Smith, Jordan O.
collection PubMed
description INTRODUCTION: Naloxone has become an important component of preventing deaths from opioid overdose. Although studies have confirmed its cost-effectiveness, naloxone is rarely prescribed proactively in case of accidental overdose. The perception still exists that a reversal agent may enable patients with opioid use disorder to continue abusing opioids without fear of death from overdose. This study was designed to determine the general public's knowledge of naloxone and their perceptions about receiving a naloxone prescription with opioid use. METHODS: Participants were recruited through Amazon Mechanical Turk (MTurk), where a link directed participants to an electronic survey. Participants were included if they were 18 years of age or greater and currently living in the United States. Participants were paid $0.10 USD via Amazon MTurk upon completing the survey. RESULTS: Four hundred five participants successfully completed the survey, and 61% were aware that there is a medication available to treat opioid overdose. The majority of participants responded positively to the idea of acquiring naloxone. Responses were evenly split for agreeing and disagreeing with the statement “naloxone is only necessary for people who abuse opioids.” Although 51% of respondents believed that having naloxone available enables people who abuse opioids, 88% agreed that naloxone is beneficial for people who accidentally overdose on opioids. A majority believed that naloxone should be made available upon request to anyone concerned about opioid overdose. DISCUSSION: Participants were generally aware of the availability of an opioid reversal agent and responded positively to 3 different methods of acquiring naloxone through their prescriber or pharmacist.
format Online
Article
Text
id pubmed-6607948
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher College of Psychiatric & Neurologic Pharmacists
record_format MEDLINE/PubMed
spelling pubmed-66079482019-07-10 Public perceptions of naloxone use in the outpatient setting Smith, Jordan O. Malinowski, Scott S. Ballou, Jordan M. Ment Health Clin Original Research INTRODUCTION: Naloxone has become an important component of preventing deaths from opioid overdose. Although studies have confirmed its cost-effectiveness, naloxone is rarely prescribed proactively in case of accidental overdose. The perception still exists that a reversal agent may enable patients with opioid use disorder to continue abusing opioids without fear of death from overdose. This study was designed to determine the general public's knowledge of naloxone and their perceptions about receiving a naloxone prescription with opioid use. METHODS: Participants were recruited through Amazon Mechanical Turk (MTurk), where a link directed participants to an electronic survey. Participants were included if they were 18 years of age or greater and currently living in the United States. Participants were paid $0.10 USD via Amazon MTurk upon completing the survey. RESULTS: Four hundred five participants successfully completed the survey, and 61% were aware that there is a medication available to treat opioid overdose. The majority of participants responded positively to the idea of acquiring naloxone. Responses were evenly split for agreeing and disagreeing with the statement “naloxone is only necessary for people who abuse opioids.” Although 51% of respondents believed that having naloxone available enables people who abuse opioids, 88% agreed that naloxone is beneficial for people who accidentally overdose on opioids. A majority believed that naloxone should be made available upon request to anyone concerned about opioid overdose. DISCUSSION: Participants were generally aware of the availability of an opioid reversal agent and responded positively to 3 different methods of acquiring naloxone through their prescriber or pharmacist. College of Psychiatric & Neurologic Pharmacists 2019-07-01 /pmc/articles/PMC6607948/ /pubmed/31293847 http://dx.doi.org/10.9740/mhc.2019.07.275 Text en © 2019 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Smith, Jordan O.
Malinowski, Scott S.
Ballou, Jordan M.
Public perceptions of naloxone use in the outpatient setting
title Public perceptions of naloxone use in the outpatient setting
title_full Public perceptions of naloxone use in the outpatient setting
title_fullStr Public perceptions of naloxone use in the outpatient setting
title_full_unstemmed Public perceptions of naloxone use in the outpatient setting
title_short Public perceptions of naloxone use in the outpatient setting
title_sort public perceptions of naloxone use in the outpatient setting
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607948/
https://www.ncbi.nlm.nih.gov/pubmed/31293847
http://dx.doi.org/10.9740/mhc.2019.07.275
work_keys_str_mv AT smithjordano publicperceptionsofnaloxoneuseintheoutpatientsetting
AT malinowskiscotts publicperceptionsofnaloxoneuseintheoutpatientsetting
AT balloujordanm publicperceptionsofnaloxoneuseintheoutpatientsetting